Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-011767

Director acquired 4,165 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Connaughton Bernadette Director 2025-05-01 Grant or award +4,165 50,952 D
Derivatives
Connaughton Bernadette Director 2025-05-01 Grant or award · Option to Purchase Common Stock +5,750 5,750 D
Loading xslF345X05/form4-05022025_080528.xml…